Ron Vale, Ph.D., is a scientific co-founder of Faze Medicines, and a leading expert in molecular motor proteins and the biophysical mechanisms underlying neurodegenerative disease. In addition to his work at Faze, Dr. Vale is a professor of cellular and molecular pharmacology at the University of California, San Francisco.
Dr. Vale was awarded the Canada Gairdner International Award for Biomedical Research in 2019, the Shaw Prize in Life Science and Medicine in 2017 and the Albert Lasker Award for Basic Medical Research in 2012. He is a fellow of the American Academy of Arts and Sciences and a member of the National Academy of Sciences. He has also been an investigator at the Howard Hughes Medical Institute for over two decades. In 2019, Dr. Vale was named executive director of the Janelia Research Campus and a vice president of HHMI. He received his Ph.D. in neuroscience from Stanford University.